EFPIA: New EU Rules May Rush Pharma Innovation Decline
According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a major revision of pharmaceutical regulations as proposed by the European Commission in April this year could shrink Europe's share of global research and development by a third to 21% by 2040, resulting in a loss of investment of €2 billion ($2.15 billion) a year.
